PRADEMAGENE ZAMIKERACEL
UNII 4UU2O40RHU

Substance Identification & Data

This profile provides standardized clinical and technical data for Prademagene Zamikeracel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4UU2O40RHU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2088280-15-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4UU2O40RHU

CAS Registry Number

2088280-15-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PRADEMAGENE ZAMIKERACEL

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

4UU2O40RHU

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C175196

National Cancer Institute reference terminology for clinical and research data.

INN ID

10827

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-133

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Prademagene Zamikeracel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PRADEMAGENE ZAMIKERACEL

Common Names & Synonyms

HUMAN CULTURE EXPANDED GENETICALLY MODIFIED AUTOLOGOUS KERATINOCYTES FOR CELL-BASED GENE THERAPY. CELLS ARE ISOLATED FROM SKIN OF THE PATIENT, EXPANDED AND TRANSDUCED WITH REPLICATION INCOMPETENT AND NON-SELF-INACTIVATING MOLONEY MURINE LEUKEMIA VIRUS (MMLV) DERIVED RETROVIRAL VECTOR ENCODING THE FUNCTIONAL COLLAGEN TYPE VII ALPHA 1 CHAIN (COL7A1) UNDER THE CONTROL OF THE MOUSE PHOSPHOGLYCEROL KINASE-1 (MPGK-1) PROMOTER GENETICALLY MODIFIED CELL

PRADEMAGENE ZAMIKERACEL [INN]

PRADEMAGENE ZAMIKERACEL [USAN]

PRADEMAGENE ZAMIKERACEL [WHO-DD]